- Some homework works: A randomized controlled trial of employees in a Chinese tech firm found that two days of work from home and three days in the office reduced quit rates, improved job satisfaction and had no impact on performance, when compared with employees who worked full-time in the office.
- $35 insulin actually started under Trump, but the real credit goes to Eli Lilly.
- Former CDC director admits “no one wanted to release negative information about Covid vaccines.”
- Per pupil school spending has more than quadrupled since 1960, although student test scores have barely budged.
- In 2021, the Biden administration pledged it would build 500,000 electric vehicle charging stations by 2030. So far, it has built only 7.
- Conflicting polls: Did more people die from the Covid vaccine than from Covid?
Category: Policy & Legislation
The Doctor’s Office is Coming to a Home Near You (Yours)
Every year I buy comprehensive blood testing from Walk-In Lab during their 20% off, end-of-the-year sales event. I select the test, pick the lab (Lab Corp or Quest Diagnostics) and pay online. I take the lab order to Quest Diagnostics located in my local Walmart. Nothing could be easier; I can even shop while I wait for them to call me for my blood draw. Prices are transparent. Lab tests that I paid just under $130 for on sale would possibly cost $500 through the hospital owned clinic that employs my doctor.
Friday Links
- New Policy on rationing kidneys: “Facilities will receive a single point for any successful kidney transplant, for example, but thanks to a ‘health equity’ performance adjustment, 1.2 points will be awarded for transplants involving patients from a low-income background.”
- A convoluted discussion of the ethics of gene selection.
- CFPB plans to remove medical debt from credit reports.
- WSJ: “Removing a credit notice for not paying medical bills will result in more unpaid bills.”
- Rare pediatric diseases, or those affecting less than 200,000 children, collectively affect 10 million children in the US with only five percent of rare diseases with any FDA-approved treatment.
- Health share of GDP is projected to reach 19.7 percent by 2032 (up from 17.3 percent in 2022).
Things to Know About Private Health Insurance
Source: Chris Pope, City Journal